[Amiodarone in antiarrhythmic therapy].

A. Petersen,E. Andersen,S. S. Sørensen,E. Sander

1984-07-30

Abstract:

What problem does this paper attempt to address?

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Xin Zhong,Hua Li,Chenguang Li,Nobel Zong,David Liem,X'avia Chan,Shuning Zhang,Youen Zhang,Xinggang Wang,Xing Wu,Wenbin Zhang,Kang Yao,Xuebo Liu,Lei Ge,Kai Hu,Juying Qian,Mario Deng,Junbo Ge

DOI: https://doi.org/10.1016/j.ijchv.2014.06.004

2014-01-01

Abstract:ObjectiveThe study aimed to analyze the risk factors and long-term outcomes associated with coronary artery aneurysms (CAAs) after successful percutaneous coronary intervention (PCI) and drug-eluting stent (DES) implantation in patients with CTOs.BackgroundThere are sporadic data available on post-procedure CAAs after transcatheter revascularization for CTOs.Methods and resultsA total of 141 patients with 149 CTOs who underwent successful CTO-PCI and DES implantation with angiographic follow-up from 2004 to 2010 were included. Patients were divided into CAA group and non-CAA group according to the presence of CAAs in the follow-up angiography. The independent predictors and major adverse cardiac events (MACEs) including cardiac death, myocardial infarction (MI) and target-vessel revascularization (TVR) were compared between two groups. The incidence of CAAs was 11.4% (17/149) after index procedure. Multivariate analysis showed that age (OR: 0.925, CI 0.873–0.980, P = 0.008), ostial occlusion (OR: 6.715, CI 1.473–30.610, P = 0.014), the parallel wire technique (OR: 6.167, CI 1.709–22.259, P = 0.005) and DES length (OR: 1.030, CI 1.002–1.058, P = 0.036) were the independent predictors of CAAs after successful CTO-PCI and DES implantation. MACEs were similar between two groups (adjusted hazard ratio 0.670; 95% CI 0.160–2.808; P = 0.584) during the 5-year follow-up.ConclusionsThe independent predictors of CAAs after successful CTO-PCI and DES implantation are age, ostial occlusion, the parallel wire technique and DES length. CAAs after index procedure are not frequently associated with adverse clinical events under dual antiplatelet therapy. Further large clinical studies are warranted to explore the clinical implications of patients with this distinct new entity.
Impact of calcification on percutaneous coronary intervention: MACE‐Trial 1‐year results

Samin K. Sharma,Ryan W. Bolduan,Manesh R. Patel,Brad J. Martinsen,Talhat Azemi,Gregory Giugliano,Jon R. Resar,Roxana Mehran,David J. Cohen,Jeffrey J. Popma,Ron Waksman

DOI: https://doi.org/10.1002/ccd.28099

IF: 2.3

2019-01-25

Catheterization and Cardiovascular Interventions

Abstract:OBJECTIVES: The Multi-center Prospective Study to Evaluate Outcomes of Moderate to Severely Calcified Coronary Lesions (MACE-Trial) was designed to provide further insight on the impact of calcification on procedural and long-term percutaneous coronary intervention outcomes.BACKGROUND: Prior studies evaluating the impact of lesion calcification on percutaneous coronary intervention outcomes are limited by: retrospective nature, pooled data from multiple studies, or lack of specificity around calcification with only operator assessment and without core lab evaluation.METHODS: The MACE-Trial was a prospective, multicenter, observational clinical study that enrolled 350 subjects at 33 sites from September 2013 to September 2015. Core lab assessed subject stratification by lesion calcification (none/mild [N = 133], moderate [N = 99], and severe [N = 114]). Endpoints were lesion success, procedural success, and 1-year major adverse cardiac events (MACEs).RESULTS: Presence of severe calcification had significant impact on lesion success ([83.3%] versus none/mild calcification [94.7%, P = 0.006]) and procedural success ([86.8%] versus moderate [95.0%, P = 0.028], and none/mild [97.7%, P = 0.001]). 1-year MACE rates were associated with presence of calcification in subjects with none/mild (4.7%), moderate (8.7%), and severe (24.4%) (P < 0.001) calcification; however, no difference was noted between none/mild and moderate (P = 0.237). The risk adjusted multivariable model identified severe calcification and decreasing eGFR as predictors of 30-day and 1-year MACE.CONCLUSIONS: In this prospective study, patients with severe calcification had significantly worse outcomes compared to those without; however, unlike previous retrospective studies, moderate calcium resulted in similar outcomes as none/mild calcium.CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov/ct2/show/NCT01930214. Unique Identifier: NCT01930214.

cardiac & cardiovascular systems
In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography.

Xiao Wang,Mitsuaki Matsumura,Gary S. Mintz,Tetsumin Lee,Wenbin Zhang,Yang Cao,Akiko Fujino,Yongqing Lin,Eisuke Usui,Yoshihisa Kanaji,Tadashi Murai,Taishi Yonetsu,Tsunekazu Kakuta,Akiko Maehara

DOI: https://doi.org/10.1016/j.jcmg.2017.05.014

IF: 16.051

2017-01-01

JACC Cardiovascular Imaging

Abstract:OBJECTIVES The aim of this study was to evaluate optical coherence tomography (OCT) and intravascular ultrasound (IVUS) versus coronary angiography in the assessment of target lesion calcification and its effect on stent expansion.BACKGROUND IVUS is more sensitive than angiography in the detection of coronary artery calcium, but the relationship among IVUS, OCT, and angiography has not been studied.METHODS Overall, 440 lesions (440 patients with stable angina) underwent OCT- and IVUS-guided stent implantation. Coronary calcification was evaluated using: 1) angiography; 2) IVUS (maximum calcium angle and the surface pattern); and 3) OCT (mean and maximum calcium angle, calcium length, and maximum calcium thickness).RESULTS Median patient age was 66 years, and 82.5% were men. Among 440 lesions, calcium was detected by angiography in 40.2%, IVUS in 82.7%, and OCT in 76.8%. The maximum calcium angle, maximum calcium thickness, and calcium length by OCT or IVUS increased in relation to the increasing severity of angiographically visible calcium. In 13.2% of lesions with IVUS-detected calcium, calcium was either not visible or was underestimated (> 90 degrees smaller maximum arc) by OCT mostly due to superficial OCT plaque attenuation. In 21.6% of lesions with IVUS calcium angle > 180 degrees, angiography did not detect any calcium; these lesions had thinner and shorter calcium deposits as assessed using OCT, and final minimum stent area was larger compared to those with angiographically visible calcium. In lesions with thinner calcium deposits by OCT, IVUS detected a smooth surface with reverberations whereas thick calcium deposits were associated with an irregular surface without reverberations.CONCLUSIONS Angiographic detection of target lesion coronary calcium (compared to intravascular imaging) has not changed in the past 2 decades, and angiographically invisible calcium (only detectable by IVUS or OCT) did not appear to inhibit stent expansion. (C) 2017 by the American College of Cardiology Foundation.
[Acute Angiographic and Clinical Outcomes of Patients with Calcified Chronic Total Occlusion Underwent Percutaneous Coronary Intervention].

Ya-ling Han,Hui-qiang Zhao,Shou-li Wang,Quan-min Jing,Ying-yan Ma,Bo Luan,Geng Wang,Fei Li

DOI: https://doi.org/10.3321/j.issn:0253-3758.2008.08.008

2008-01-01

Abstract:OBJECTIVE:To evaluate the in-hospital outcome of patients with calcified chronic total occlusion (CTO) lesion underwent percutaneous coronary intervention (PCI). METHODS:The clinic and lesion characteristics as well as acute PCI outcome were analyzed in 726 patients with calcified CTO [624 detected by coronary angiography (CAG) and 102 detected by intravascular ultrasound (IVUS)] and received PCI therapy from June 1995 to February 2007 in our department. RESULTS:There were 728 diseased vessels with 732 lesions in these patients. Total procedure success rate (80.6% vs. 89.2%, P < 0.05) and the lesion success rate (80.2% vs. 88.2%, P < 0.05) were significantly lower in calcified CTO detected by CAG compared to that detected by IVUS. The causes of procedure failures in CAG detected patients were as follows: 87 guide failure, 21 balloon failure, 8 procedure related complications and 5 low TIMI blood flow (grade 2) at the end of PCI procedure. The causes of procedure failures in IVUS detected patients were as follows: 7 guide wire failure, 2 balloon failure, 1 procedure related complications and 1 patient with low TIMI blood flow (grade 2). The in-hospital major adverse cardiac events (MACE) rate was 1.1% in CAG detected calcified CTO and 1.0% in IVUS detected calcified CTO (P > 0.05). CONCLUSION:PCI therapy resulted in satisfactory procedure success rate and in-hospital outcome for patients with calcified CTO and IVUS is helpful for further increasing the PCI procedure success rate in patients with calcified CTO.
Clinical outcomes of percutaneous coronary intervention for severely calcified lesions: comparison between the morphologies of severely calcified coronary lesions

Yoriyasu Suzuki,Masahiro Uehara,Hirohiko Ando,Akihiro Suzuki,Akira Murata,Hiroaki Matsuda,Takahiro Tokuda,Tetsuya Amano

DOI: https://doi.org/10.1007/s00380-024-02466-7

2024-09-27

Heart and Vessels

Abstract:Existing studies evaluating the comparison of clinical outcome of percutaneous coronary intervention (PCI) for severe calcified coronary lesions are limited, and the clinical outcomes of PCI for different morphologies of calcified lesions are controversial. Overall, consecutive 576 lesions with severe calcification that were treated with PCI from 2010 to 2021 at Nagoya Heart Center were investigated. All lesions were assessed using invasive coronary angiogram (CAG) or computed tomography-CAG at 12 months after DES implantation. We divided the patients into three groups based on the results of intravascular ultrasound (IVUS) imaging (concentric calcified lesion [CC] n = 273, eccentric calcified lesion [EC] n = 217, calcified nodule [CN] n = 86). The clinical and angiographic outcomes of each group were investigated retrospectively to compare the prognosis between the three groups and identify predictive factors for the device-oriented composite end points (DoCE). There were no differences in patient characteristics among the three groups, except that there were significantly more patients on dialysis in the CN group. The incidence of DoCE was significantly higher in the CN group than in the other groups (CC; 18.3% vs. EC; 23.5% vs. CN; 36.0%; Log-Rank test; p = 0.001). Cox regression analysis showed that the independent predictors of DoCE were CN, insulin use, hemodialysis, right coronary artery lesions, and calcium cracks. The incidence of DoCE was significantly higher in the CN group. Calcium cracks are crucial for improving outcomes in severely calcified lesions, being key predictors of DoCE.

cardiac & cardiovascular systems,peripheral vascular disease
Full-Moon Coronary Calcification as Detected With Computed Tomography Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention

Giuseppe Panuccio,Gerald S Werner,Salvatore De Rosa,Daniele Torella,David M Leistner,Patrick T Siegrist,Arash Haghikia,Carsten Skurk,Kambis Mashayekhi,Ulf Landmesser,Youssef S Abdelwahed

DOI: https://doi.org/10.1016/j.amjcard.2024.05.008

2024-07-01

Abstract:"Full moon" is a central calcification that occludes the entire vessel on coronary computed tomography angiography (CCTA). We examined the association of full moon calcification as identified by CCTA, on clinical and procedural outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We studied patients who underwent elective CTO-PCI in 2 European centers and had preprocedural CCTA. The primary end point was the inability to cross the lesion and/or the need for extensive debulking techniques. Secondary end points were procedural success, in-hospital cardiac mortality, the need for extensive debulking techniques, myocardial infarction, major adverse cardiac events (defined as in-hospital death, myocardial infarction, and clinically driven target vessel revascularization), and stent thrombosis. Secondary procedural end points included procedural time, fluoroscopy time, number of guidewires and balloons, stent length, number and diameter, and contrast volume. Multivariable logistic regression analysis was performed, identifying potential covariates related to the primary outcome according to knowledge and previous studies. Subsequently, a stepwise selection approach was performed to select factors with the greatest predictive value. Of 140 patients included, 28 (20%) had a full moon calcified CTO plaque. Patients in the full moon group were older and had more cardiovascular risk factors. There was not significant difference in the need for retrograde approach and anterograde dissection and reentry techniques between the full moon group and the other groups (32.1% vs 37.5%, p = 0.59 and 0% vs 1.7%, p = 0.47, respectively). Patients in the full moon group had greater incidence of the primary outcome than did those who did not have full moon morphology (53.5% vs 12.5%, p <0.001). On multivariable analysis that included chronic kidney failure and previous coronary artery bypass surgery, full moon calcification was associated with greater incidence of the primary end point (odds ratio 6.5, 95% confidence interval 2.1 to 20.5, p = 0.001). Moreover, less procedural success (71.4% vs 87.5%, p = 0.03), greater incidence of coronary perforations (14.2% vs 3.5%, p <0.02), and greater procedural (172.5 [118.0 to 237.5] vs 144.0 [108.50 to 174.75], p = 0.02) and fluoroscopic time (62.6 [38.1 to 83.0] vs 42.8 [29.5 to 65.7], p = 0.03) were observed in the full moon group. Overall major adverse cardiac events did not differ between the 2 groups (1 patient in the full moon group vs 1 patient in the non-full moon group; 3.5% vs 0.8%, p = 0.29). In conclusion, full moon calcification on CCTA was independently associated with procedural complexity and adverse outcomes in CTO-PCI.
Comparison of different calcium modification strategies for coronary calcified nodules: insights from optical coherence tomography

K Yasumura,A Koshy,Y Vengrenyuk,S Minatoguchi,P Krishnamoorthy,A Hooda,R Sharma,V Kapur,J Sweeny,S Sharma,A Kini

DOI: https://doi.org/10.1093/eurheartj/ehae666.2406

IF: 39.3

2024-10-30

European Heart Journal

Abstract:Background The optimal treatment strategy for coronary calcified nodules (CN) remains uncertain. Purpose We sought to compare the safety and efficacy of different calcium modification strategies for managing CN using optical coherence tomography (OCT). Methods In this single-center retrospective cohort study, consecutive patients undergoing OCT-guided percutaneous coronary intervention (PCI) for severely calcified lesions using rotational atherectomy (RA), orbital atherectomy (OA), or intravascular lithotripsy (IVL) between January 2017 and December 2022 were included. OCT analysis was performed through our institutional core-laboratory to identify CN, assess plaque characteristics, and evaluate post-stent optimization. Primary outcomes were minimum stent area (MSA) and MSA at CN site post-PCI. One-year target vessel failure (TVF), defined as a composite of cardiac death, target-vessel myocardial infarction, or ischemia-driven target vessel revascularization, was also recorded. Results Among a total of 154 patients with 158 lesions, CN was identified in 54 lesions (34.2%) and managed with RA (39%, n=21), OA (33%, n=18), or IVL (28%, n=15). The IVL group exhibited a larger minimal lumen diameter, maximum calcium arc, and maximum calcium thickness at baseline. Post-PCI OCT demonstrated comparable MSA (RA: 5.91 ± 0.33mm2, OA: 5.94 ± 0.38mm2, IVL: 6.46 ± 0.45mm2; p=0.61) and MSA at CN site (6.77 ± 0.49mm2, 6.71 ± 0.51mm2, 7.13 ± 0.59mm2, respectively; p=0.87) after adjusting for procedural and morphologic factors among the groups. The incidence of TVF at one year was similar among the groups. Conclusions In patients undergoing PCI for severely calcified lesions with CN, comparable procedural and clinical outcomes can be achieved using RA, OA, or IVL. The equivalence across these techniques underscores a role for individualized decision-making integrating patient- and lesion-specific characteristics, as well as center expertise when selecting a treatment strategy for CN.OCT findings and clinical outcomes

cardiac & cardiovascular systems
Impact of Coronary Chronic Total Occlusion on Long-term Clinical Outcome in Patients with Unprotected Left Main Disease Undergoing Percutaneous Coronary Intervention

Imad Sheiban,Filippo Figini,Valeria Gaspartto,Claudio Moretti,Filippo Leonardo,Shaoliang Chen,Fabrizio D'Ascenzo

DOI: https://doi.org/10.1097/cd9.0000000000000071

2022-01-01

Cardiology Discovery

Abstract:Objectives: Reported data regarding the prevalence, prognostic impact, and safety and efficacy of revascularization of coronary chronic total occlusion (CTO) in patients with left main coronary artery (LMCA) disease who undergo percutaneous coronary intervention (PCI) are scarce. The aim of the present study was to compare clinical outcomes among patients with LMCA disease undergoing PCI. Outcomes were compared between those with and without coronary CTO and between those with CTO who had successful and unsuccessful CTO recanalization procedures. Methods: All consecutive patients with significant LMCA disease (>50% stenosis at coronary angiography) who underwent PCI between July 2014 and December 2018 were retrospectively included in our study. The primary endpoint of the study was long-term mortality. Secondary endpoints included the incidence of myocardial infarction, repeat percutaneous or surgical revascularization, stroke, and stent thrombosis. Results: Between July 2014 and December 2018, 578 patients underwent PCI for LMCA disease at Pederzoli Hospital and University of Turin were enrolled. They were divided into 3 groups: group A: 374 (65%) patients without CTO, group B: 108 (19%) patients with untreated or unsuccessfully treated CTO, and group C: 96 (17%) patients with successfully treated CTO. At a median follow-up of (1090 ± 279) days, there were no statistically significant differences between the groups in terms of the primary and secondary endpoints. However, there was a trend towards higher mortality in patients with untreated or unsuccessfully treated CTO (13% vs. 19% vs. 14% in groups A, B, and C, respectively; P = 0.12). The primary and secondary endpoints were further analyzed based on the presence or absence of myocardial viability: subgroup C1: 54 (56%) patients with successful percutaneous transluminal coronary angioplasty (PTCA) having viability, and subgroup C2: 42 (44%) patients with successful PTCA not having viability. There was a trend toward a statistically significant higher rate of death among patients in group B, who underwent unsuccessful recanalization with viable myocardium (19% vs. 9% vs. 19% in groups B, C1, and C2, respectively, P = 0.05). On multivariable analysis, the propensity for successful revascularization of CTO was associated with a reduced risk of death (P = 0.01; odds ratio, 0.75; 95% confidence interval: 0.62–0.87). Conclusions: Among patients with LMCA disease undergoing PCI, CTO represents a common finding associated with worse prognosis. Successful revascularization of CTO in patients with viable myocardium appears to significantly improve prognosis.
Chronic total occlusion percutaneous coronary intervention of anomalous coronary arteries: insights from the PROGRESS CTO registry

Gustavo M. Hirata,Athanasios Rempakos,A. Walker Boyd,Michaella Alexandrou,Deniz Mutlu,James W. Choi,Paul Poommipanit,Jaikirshan J. Khatri,Laura Young,Rhian Davies,Sevket Gorgulu,Farouc A. Jaffer,Raj Chandwaney,Brian Jefferson,Basem Elbarouni,Lorenzo Azzalini,Kathleen E. Kearney,Khaldoon Alaswad,Mir B. Basir,Oleg Krestyaninov,Dmitrii Khelimskii,Nazif Aygul,Nidal Abi‐Rafeh,Ahmed ElGuindy,Omer Goktekin,Bavana V. Rangan,Olga C. Mastrodemos,Ahmed Al‐Ogaili,Yader Sandoval,M. Nicholas Burke,Emmanouil S. Brilakis,Jarrod D. Frizzell

DOI: https://doi.org/10.1002/ccd.31248

IF: 2.3

2024-10-05

Catheterization and Cardiovascular Interventions

Abstract:Background There is limited information about the frequency and outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI) in anomalous coronary arteries (ACA). Methods We examined the clinical and angiographic characteristics and procedural outcomes of CTO PCI in ACA among 14,173 patients who underwent 14,470 CTO PCIs at 46 US and non‐US centers between 2012 and 2023. Results Of 14,470 CTO PCIs, 36 (0.24%) were CTO PCIs in an ACA. ACA patients had similar baseline characteristics as those without an ACA. The type of ACA in which the CTO lesion was found were as follows: anomalous origin of the right coronary artery (ARCA) (17, 48.5%), anomalous origin of left circumflex coronary artery (9, 25.7%), left anterior descending artery and left circumflex artery with separate origins (4, 11.4%), anomalous origin of the left anterior descending artery (2, 5.7%), dual left anterior descending artery (2, 5.7%) and woven coronary artery 1 (2.8%). The Japan CTO score was similar between both groups (2.17 ± 1.32 vs 2.38 ± 1.26, p = 0.30). The target CTO in ACA patients was more likely to have moderate/severe tortuosity (44% vs 28%, p = 0.035), required more often use of retrograde approach (27% vs 12%, p = 0.028), and was associated with longer procedure (142.5 min vs 112.00 min [74.0, 164.0], p = 0.028) and fluoroscopy (56 min [40, 79 ml] vs 42 min [25, 67], p = 0.014) time and higher contrast volume (260 ml [190, 450] vs 200 ml [150, 300], p = 0.004) but had similar procedural (91.4% vs 85.6%, p = 0.46) and technical (91.4% vs 87.0%, p = 0.59) success. No major adverse cardiac events (MACE) were seen in ACA patients (0% [0] vs 1.9% [281] in non‐ACA patients, p = 1.00). Two coronary perforations were reported in ACA CTO PCI (p = 0.7 vs. non‐ACA CTO PCI). Conclusions CTO PCI of ACA comprise 0.24% of all CTO PCIs performed in the PROGRESS CTO registry and was associated with higher procedural complexity but similar technical and procedural success rates and similar MACE compared with non‐ACA CTO PCI.

cardiac & cardiovascular systems
Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one‐year clinical outcomes

Federico Oliveri,Martijn J. H. van Oort,Ibtihal Al Amri,Brian O. Bingen,Bimmer E. Claessen,Aukelien C. Dimitriu‐Leen,Joelle Kefer,Hany Girgis,Tessel Vossenberg,Frank van der,J. Wouter Jukema,Jose M. Montero‐Cabezas

DOI: https://doi.org/10.1002/ccd.31207

IF: 2.3

2024-09-02

Catheterization and Cardiovascular Interventions

Abstract:Background Calcification within chronic total occlusions (CTO) is strongly associated with worse outcomes. Despite the excellent success and safety of intravascular lithotripsy (IVL) in heavily calcified lesions, evidence in CTO remains scarce. Aim This study aimed to evaluate the procedural and long‐term clinical outcomes of IVL in heavily calcified CTO. Methods Patients who underwent IVL between 2019 and 2024 from an ongoing prospective multicenter registry were eligible for inclusion. Patients were therefore classified in CTO and non‐CTO groups. The efficacy and safety endpoints of CTO percutaneous coronary interventions were defined according to the CTO‐ARC consensus. In‐hospital major adverse cardiovascular events (MACE) included cardiac death, nonfatal myocardial infarction and target lesion revascularization (TVR). Results A total of 404 patients underwent IVL, of which the treated lesion was a CTO in 33 (8.2%). The mean J‐CTO score was 2.3 ± 1.1. Device success showed no significant difference between CTO and non‐CTO groups (100% vs 98.4%; p = 0.35). Comparable technical success with residual stenosis <30% was observed in both groups (90.1% in CTO vs 89.2% in non‐CTO, p = 0.83). The incidence of MACE was similar across groups during hospital stays (CTO 6.0% vs. non‐CTO 1.9%, p = 0.12), at 30‐day (CTO 9.1% vs. non‐CTO 3.0%, p = 0.07), and at 12‐month follow‐up (CTO 9.1% vs. non‐CTO 7.3%, p = 0.70). Conclusion IVL provides high procedural success and consistent clinical outcomes in both CTO and non‐CTO cases, reinforcing its role in managing heavily calcified coronary lesions.

cardiac & cardiovascular systems
Tumour spread through the obturator foramen.

R. Abratt,A. Pontin,T. Roman,S. Price

DOI: https://doi.org/10.1259/0007-1285-58-691-673

1985-07-01

British Journal of Radiology

Abstract:A patient presented with tumour masses—diagnosed as multicystic peritoneal mesothelioma—within the true pelvis, superficial perineal pouch including the penis and medial thigh. The tumour's mode of spread could not be determined clinically. Computerised tomography (CT) showed this to be through the obturator foramen, a previously undocumented route of spread. A 47-year-old man presented in January 1981 with a weak urinary stream and a swelling in his perineum. Examination revealed a fixed mass (approximately 4 × 3 cm in size) in the left anterior perineum involving the root of his penis and extending into his medial thigh. Rectal examination revealed an indurated anterior rectal wall which precluded the delineation of normal pelvic structures. Initial investigations included a full blood count, acid phosphatase, chest radiograph and an excretory urogram, all of which were normal. An ascending urethrogram showed extensive narrowing of the bulbous urethra. A descending urethrogram showed no obstruction with...
Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry

Giuseppe Vadalà,Alfredo R Galassi,Gerald S Werner,George Sianos,Nicolaus Boudou,Roberto Garbo,Laura Maniscalco,Alexander Bufe,Alexander Avran,Gabriele L Gasparini,Eugenio La Scala,Andrew Ladwiniec,Meruzhan Saghatelyan,Omer Goktekin,Sevket Gorgulu,Nicolaus Reifart,Pierfrancesco Agostoni,Sudhir Rathore,Mohamed Ayoub,Michael Behnes,Iskander Atmowihardjo,Mario Iannaccone,Roberto Diletti,Carlo Di Mario,Kambis Mashayekhi,On Behalf Of The Euro Cto Investigators,Alfredo R. Galassi,Gerald S. Werner,Gabriele L. Gasparini,on behalf of the EURO CTO investigators

DOI: https://doi.org/10.4244/eij-d-23-00490

2024-02-01

EuroIntervention

Abstract:BACKGROUND: Percutaneous coronary interventions (PCI) of chronic total occlusions (CTO) have reached high procedural success rates thanks to dedicated equipment, evolving techniques, and worldwide adoption of state-of-the-art crossing algorithms.AIMS: We report the contemporary results of CTO PCIs performed by a large European community of experienced interventionalists. Furthermore, we investigated the impact of different risk factors for procedural major adverse cardiac and cerebrovascular events (MACCE) and trends of employment of specific devices like dual lumen microcatheters, guiding catheter extensions, intravascular ultrasound and calcium-modifying tools.METHODS: We evaluated data from 8,673 CTO PCIs included in the European Registry of Chronic Total Occlusion (ERCTO) between January 2021 and October 2022.RESULTS: The overall technical success rate was 89.1% and was higher in antegrade as compared with retrograde cases (92.8% vs 79.3%; p<0.001). Compared with antegrade procedures, retrograde procedures had a higher complexity of attempted lesions (Japanese CTO [J-CTO] score: 3.0±1.0 vs 1.9±1.2; p<0.001), a higher procedural and in-hospital MACCE rate (3.1% vs 1.2%; p<0.018) and a higher perforation rate with and without tamponade (1.5% vs 0.4% and 8.3% vs 2.1%, respectively; p<0.001). As compared with mid-volume operators, high-volume operators had a higher technical success rate in antegrade and retrograde procedures (93.4% vs 91.2% and 81.5% vs 69.0%, respectively; p<0.001), and had a lower MACCE rate (1.47% vs 2.41%; p<0.001) despite a higher mean complexity of the attempted lesions (J-CTO score: 2.42±1.28 vs 2.15±1.27; p<0.001).CONCLUSIONS: The adoption of different recanalisation techniques, operator experience and the use of specific devices have contributed to a high procedural success rate despite the high complexity of the lesions documented in the ERCTO.

cardiac & cardiovascular systems
The impact of successful chronic total occlusion percutaneous coronary intervention on clinical outcomes: a tertiary single-center analysis

Maximilian Will,Konstantin Schwarz,Simone Aufhauser,Gregor Leibundgut,Elisabeth Schmidt,David Mayer,Paul Vock,Josip A. Borovac,Chun Shing Kwok,Gudrun Lamm,Julia Mascherbauer,Thomas Weiss

DOI: https://doi.org/10.3389/fcvm.2024.1447829

IF: 3.6

2024-09-27

Frontiers in Cardiovascular Medicine

Abstract:Background The benefit of chronic total occlusion (CTO)-percutaneous coronary intervention (PCI) is controversial because of a lack of high-quality evidence. We aim to evaluate the impact of CTO-PCI on symptoms, quality of life and mortality. Methods We conducted a retrospective single center study of patients with CTO-PCI in a tertiary center in Austria. The study outcomes were Canadian Cardiovascular Society (CCS) angina score, quality of life measured by Seattle Angina Questionnaire (SAQ), and death at median follow up for patients with successful vs. failed CTO-PCI. Results A total of 300 patients underwent CTO-PCI for coronary artery disease, of which 252 (84%) were technically successful with median follow up of 3.4 years. There were no significant differences in in-hospital or all-cause mortality, major adverse cardiovascular event, or stent-related complications between the groups of failed and successful CTO-PCI. Among patients with successful CTO-PCI there was a significant improvement in CCS score, which was not found for the group with failed CTO-PCI. Successful reopening was associated with significant benefits of the SAQ domains of angina with stressful activity [3.7 ± 0.9 vs. 3.1 ± 0.5, p = 0.004, use of nitrates (4.7 ± 0.5 vs. 3.0 ± 1.0) p = 0.005] and satisfaction from angina relief (4.4 ± 1.1 vs. 3.6 ± 1.4 p < 0.001). Conclusion While there was no significant difference in mortality, successful CTO-PCI was associated with greater reduction in angina and the use of nitrates compared to unsuccessful CTO-PCI.

cardiac & cardiovascular systems
The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease

Han-Young Jin,Jonathan R Weir-McCall,Jonathon A Leipsic,Jang-Won Son,Stephanie L Sellers,Michael Shao,Philipp Blanke,Amir Ahmadi,Martin Hadamitzky,Yong-Jin Kim,Edoardo Conte,Daniele Andreini,Gianluca Pontone,Matthew J Budoff,Ilan Gottlieb,Byoung Kwon Lee,Eun Ju Chun,Filippo Cademartiri,Erica Maffei,Hugo Marques,Pedio de Araujo Goncalves,Sanghoon Shin,Jung Hyun Choi,Renu Virmani,Habib Samady,Peter H Stone,Daniel S Berman,Jagat Narula,Leslee J Shaw,Jeroen J Bax,Kavitha Chinnaiyan,Gilbert Raff,Mouaz H Al-Mallah,Fay Y Lin,James K Min,Ji Min Sung,Sang-Eun Lee,Hyuk-Jae Chang

DOI: https://doi.org/10.1016/j.jcmg.2020.08.036

Abstract:Objectives: The aim of the current study was to explore the impact of plaque calcification in terms of absolute calcified plaque volume (CPV) and in the context of its percentage of the total plaque volume at a lesion and patient level on the progression of coronary artery disease. Background: Coronary artery calcification is an established marker of risk of future cardiovascular events. Despite this, plaque calcification is also considered a marker of plaque stability, and it increases in response to medical therapy. Methods: This analysis included 925 patients with 2,568 lesions from the PARADIGM (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging) registry, in which patients underwent clinically indicated serial coronary computed tomography angiography. Plaque calcification was examined by using CPV and percent CPV (PCPV), calculated as (CPV/plaque volume) × 100 at a per-plaque and per-patient level (summation of all individual plaques). Results: CPV was strongly correlated with plaque volume (r = 0.780; p < 0.001) at baseline and with plaque progression (r = 0.297; p < 0.001); however, this association was reversed after accounting for plaque volume at baseline (r = -0.146; p < 0.001). In contrast, PCPV was an independent predictor of a reduction in plaque volume (r = -0.11; p < 0.001) in univariable and multivariable linear regression analyses. Patient-level analysis showed that high CPV was associated with incident major adverse cardiac events (hazard ratio: 3.01: 95% confidence interval: 1.58 to 5.72), whereas high PCPV was inversely associated with major adverse cardiac events (hazard ratio: 0.529; 95% confidence interval: 0.229 to 0.968) in multivariable analysis. Conclusions: Calcified plaque is a marker for risk of adverse events and disease progression due to its strong association with the total plaque burden. When considered as a percentage of the total plaque volume, increasing PCPV is a marker of plaque stability and reduced risk at both a lesion and patient level. (Progression of Atherosclerotic Plaque Determined by Computed Tomographic Angiography Imaging [PARADIGM]; NCT02803411).
Role of calcification in J-CTO score: a viewpoint of intraplaque guidewire tracking techniques

Shih-Chi Liu Chien-Lin Lee Jen-Fang Cheng Jiunn-Yang Chiang Cheng-Ting Tsai Chi-Jen Chang Chia-Pin Lin Chi-Hung Huang Jun-Ting Liou Chia-Ti Tsai Yi-Chih Wang Juey-Jen Hwang a Cardiovascular Division,Department of Internal Medicine,Fu Jen Catholic University Hospital,New Taipei City,Taiwanb Cardiovascular Division,Department of Internal Medicine,Far Eastern Memorial Hospital,New Taipei City,Taiwanc Cardiovascular Division,Department of Internal Medicine,National Taiwan University Hospital,Taipei,Taiwand Cardiovascular Division,Department of Internal Medicine,MacKay Memorial Hospital,Taipei,Taiwane Cardiovascular Division,Department of Internal Medicine,Chang Gung Memorial Hospital,Taoyuan,Taiwanf Cardiovascular Division,Department of Internal Medicine,Cathay General Hospital,Taipei,Taiwang Cardiovascular Division,Department of Internal Medicine,China Medical University Hsinchu Hospital,Zhubei City,Taiwan

DOI: https://doi.org/10.1080/07853890.2024.2396076

IF: 5.348

2024-08-30

Annals of Medicine

Abstract:Background As the burden and distribution of calcification within chronic total occlusion (CTO) lesions can be diverse, its effect on CTO recanalization using multiple devices and techniques is debatable. This study investigated the role of calcification in wiring-based intraplaque tracking techniques for CTO recanalization.

medicine, general & internal
Rotational, orbital atherectomy and intravascular lithotripsy for coronary calcified nodules: insights from optical coherence tomography

Keisuke Yasumura,Anoop N. Koshy,Manish Vinayak,Yuliya Vengrenyuk,Shingo Minatoguchi,Parasuram Krishnamoorthy,Amit Hooda,Raman Sharma,Vishal Kapur,Joseph Sweeny,Samin K. Sharma,Annapoorna S. Kini

DOI: https://doi.org/10.1002/ccd.31246

IF: 2.3

2024-10-25

Catheterization and Cardiovascular Interventions

Abstract:Background The optimal treatment strategy for coronary calcified nodules (CN) remains uncertain. We aimed to evaluate the efficacy and safety of different calcium modification strategies, including rotational atherectomy (RA), orbital atherectomy (OA), and intravascular lithotripsy (IVL) for managing CN with optical coherence tomography (OCT) guidance. Methods Consecutive patients undergoing OCT‐guided percutaneous coronary intervention (PCI) for severely calcified lesions using RA, OA, or IVL between January 2017 and December 2022 were included. Primary endpoint was minimum stent area (MSA) post‐PCI. Secondary endpoints included MSA at CN site and 1‐year target vessel failure (TVF), defined as a composite of cardiac death, target‐vessel myocardial infarction, or target vessel revascularization. Results Among 154 patients and 158 lesions, CN was identified in 54 lesions (34.2%) and managed with RA (39%, n = 21), OA (33%, n = 18), or IVL (28%, n = 15). The IVL group exhibited a larger minimal lumen diameter, maximum calcium arc, and maximum calcium thickness. Post‐PCI OCT demonstrated comparable MSA (RA: 6.23 ± 0.34 mm2, OA: 5.75 ± 0.39 mm2, IVL: 6.24 ± 0.46 mm2; p = 0.62) and MSA at CN site (7.17 ± 0.43 mm2, 6.46 ± 0.49 mm2, 7.86 ± 0.56 mm2, respectively; p = 0.55) after adjusting for morphologic factors. The incidence of TVF at 1 year was similar among the group (RA: 19.0%, OA: 22.2%, IVL: 13.3%, p = 0.81). Conclusions In patients undergoing PCI for CN, similar procedural and clinical outcomes can be achieved using RA, OA, or IVL. These findings warrant further investigation in larger, prospective trials.

cardiac & cardiovascular systems
Impact of calcified plaque volume on technical and 3-year outcomes after transcarotid artery revascularization

Leanne E Grafmuller,Daniel J Lehane,Christian L Dohring,Zachary R Zottola,Doran S Mix,Karina A Newhall,Adam J Doyle,Michael C Stoner

DOI: https://doi.org/10.1016/j.jvs.2023.03.017

Abstract:Objective: We sought to quantify the percent calcification within carotid artery plaques and assess its impact on percent residual stenosis and rate of restenosis in patients undergoing transcarotid artery revascularization for symptomatic and asymptomatic carotid artery stenosis. Methods: A retrospective review of prospectively collected institutional Vascular Quality Initiative data was performed to identify all patients undergoing transcarotid artery revascularization from December 2015 to June 2021 (n = 210). Patient and lesion characteristics were extracted. Using a semiautomated workflow, preoperative computed tomography head and neck angiograms were analyzed to determine the calcified plaque volume in distal common carotid artery and internal carotid artery plaques. Intraoperative digital subtraction angiograms were reviewed to calculate the percent residual stenosis post-intervention according to North American Symptomatic Carotid Endarterectomy Trial criteria. Peak systolic velocity and end-diastolic velocity were extracted from outpatient carotid duplex ultrasound examinations. Univariate logistic regression was performed to analyze the relationship of calcium volume percent and Vascular Quality Initiative lesion calcification to percent residual stenosis in completion angiograms. Kaplan-Meier analysis examined the relationship between calcium volume percent and in-stent stenosis over 36 months. Results: One hundred ninety-seven carotid arteries were preliminarily examined. Predilation was performed in 87.4% of cases with a mean balloon diameter of 5.1 ± 0.7 mm and a mean stent diameter was 8.8 ± 1.1 mm. The mean calcium volume percent was 11.9 ± 12.4% and the mean percent residual stenosis was 16.1 ± 15.6%. Univariate logistic regression demonstrated a statistically significant difference between calcium volume percent and percent residual stenosis (odds ratio [OR], 1.324; 95% confidence interval [CI], 1.005-1.746; P = .046). Stratified by quartile, only the top 25% of calcified plaques (>18.7% calcification) demonstrated a statistically significant association with higher percent residual stenosis (OR, 2.532; 95% CI, 1.049-6.115; P =.039). There was no statistical significance with lesion calcification (OR, 1.298; 95% C,: 0.980-1.718; P = .069). A Kaplan-Meier analysis demonstrated a statistically significant increase in the rate of in-stent stenosis during a 36-month follow-up for lesions containing >8.2% calcium volume (P = .0069). Conclusions: A calcium volume percent of >18.7% was associated with a higher percent residual stenosis, and a calcium volume percent of >8.2% was associated with higher in-stent stenosis at 36 months. There was one clinically diagnosed stroke during the follow-up period, demonstrating the overall safety of the procedure.
Intravascular imaging-guided percutaneous coronary intervention for heavily calcified coronary lesions: a systematic review and meta-analysis

Doosup Shin,David Hong,Mandeep Singh,Seung Hun Lee,Koshiro Sakai,Ali Dakroub,Sarah Malik,Akiko Maehara,Evan Shlofmitz,Gregg W. Stone,Allen Jeremias,Richard A. Shlofmitz,Joo Myung Lee,Joo-Yong Hahn,Ziad A. Ali

DOI: https://doi.org/10.1007/s10554-024-03150-7

2024-06-15

The International Journal of Cardiovascular Imaging

Abstract:Although multiple randomized clinical trials (RCTs) have shown that intravascular imaging (IVI)-guided percutaneous coronary intervention (PCI) is associated with improved clinical outcomes compared with angiography-guided PCI, its benefits specifically in calcified coronary lesions is unclear due to the small number of patients included in individual trials. We performed a meta-analysis of RCTs to investigate benefits of IVI-guided PCI compared with angiography-guided PCI in heavily calcified coronary lesions. The primary endpoint was major adverse cardiac events (MACE), a composite of cardiac death, target-vessel or target-lesion myocardial infarction, and target-vessel or target lesion revascularization. Pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated by using a random-effects meta-analysis based on the restricted maximum likelihood method. A search PubMed, EMBASE, and Cochrane Library from their inception to January 2024 identified 4 trials that randomized 1319 patients with angiographically moderate or severe or severe coronary calcification to IVI-guided ( n = 702) vs. angiography-guided PCI ( n = 617). IVI-guided PCI resulted in a significantly lower odds of MACE (OR 0.57, 95% CI 0.40–0.80) compared with angiography-guided PCI at a weighted median follow-up duration of 27.3 months. There was no evidence of heterogeneity among the studies ( I 2 = 0.0%), and included trials were judged to be low risk of bias. Compared with angiography-guided PCI, IVI-guided PCI was associated with a significantly lower MACE in angiographically heavily calcified coronary lesions.

radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems
Survival and intermediate-term effects of cyclosporine-treated heart transplantation.

P. Sakornpant,S. Athapaisalsarudee,S. Thanami,S. Aswapiyanond,S. Sangchote,W. Warinsirikul,P. Lertpradit,S. Jiyodsilp

IF: 1.014

1992-10-01

Transplantation Proceedings

Abstract:
Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification

Michael S Lee,Jonathan S Gordin,Gregg W Stone,Samin K Sharma,Shigeru Saito,Ehtisham Mahmud,Jeff Chambers,Philippe Généreux,Richard Shlofmitz

DOI: https://doi.org/10.1002/ccd.27339

Abstract:Severe coronary artery calcification (CAC) increases the complexity of percutaneous coronary intervention (PCI) by inhibiting optimal stent expansion, leading to an increased risk of death, myocardial infarction, repeat revascularization, and stent thrombosis. Coronary atherectomy modifies and debulks calcified plaque to facilitate PCI. Although there is no clear consensus, and further studies are needed, the decision to perform atherectomy should be based upon the presence of fluoroscopic CAC or with the use of intravascular imaging. The management of CAC in the modern era relies on rotational and orbital atherectomy to prepare the lesion to facilitate stent delivery and optimal expansion. While the two technologies differ in equipment, technique, and mechanism of action, the available literature suggests similar efficacy and safety of the two systems, although head-to-head comparisons are limited. While rotational and orbital atherectomy have been shown to have excellent procedural success in terms of facilitating stent delivery, no system has been shown to reduce long-term major adverse cardiovascular events, although the definitive trial for orbital atherectomy has not been completed. Additional trials are needed to find the population who would derive the most benefit of atherectomy and to compare the two systems in a prospective manner.

[Amiodarone in antiarrhythmic therapy].

Clinical Outcomes and Risk Factors of Coronary Artery Aneurysms after Successful Percutaneous Coronary Intervention and Drug-Eluting Stent Implantation for Chronic Total Occlusions

Impact of calcification on percutaneous coronary intervention: MACE‐Trial 1‐year results

In Vivo Calcium Detection by Comparing Optical Coherence Tomography, Intravascular Ultrasound, and Angiography.

[Acute Angiographic and Clinical Outcomes of Patients with Calcified Chronic Total Occlusion Underwent Percutaneous Coronary Intervention].

Clinical outcomes of percutaneous coronary intervention for severely calcified lesions: comparison between the morphologies of severely calcified coronary lesions

Full-Moon Coronary Calcification as Detected With Computed Tomography Angiography in Chronic Total Occlusion Percutaneous Coronary Intervention

Comparison of different calcium modification strategies for coronary calcified nodules: insights from optical coherence tomography

Impact of Coronary Chronic Total Occlusion on Long-term Clinical Outcome in Patients with Unprotected Left Main Disease Undergoing Percutaneous Coronary Intervention

Chronic total occlusion percutaneous coronary intervention of anomalous coronary arteries: insights from the PROGRESS CTO registry

Intravascular lithotripsy in heavily calcified chronic total occlusion: procedural and one‐year clinical outcomes

Tumour spread through the obturator foramen.

Contemporary outcomes of chronic total occlusion percutaneous coronary intervention in Europe: the ERCTO registry

The impact of successful chronic total occlusion percutaneous coronary intervention on clinical outcomes: a tertiary single-center analysis

The Relationship Between Coronary Calcification and the Natural History of Coronary Artery Disease

Role of calcification in J-CTO score: a viewpoint of intraplaque guidewire tracking techniques

Rotational, orbital atherectomy and intravascular lithotripsy for coronary calcified nodules: insights from optical coherence tomography

Impact of calcified plaque volume on technical and 3-year outcomes after transcarotid artery revascularization

Intravascular imaging-guided percutaneous coronary intervention for heavily calcified coronary lesions: a systematic review and meta-analysis

Survival and intermediate-term effects of cyclosporine-treated heart transplantation.

Orbital and rotational atherectomy during percutaneous coronary intervention for coronary artery calcification